{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:17:17Z","timestamp":1771395437322,"version":"3.50.1"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2026.1746702","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:32:44Z","timestamp":1771392764000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: Reviews in: multiple sclerosis and neuroimmunology"],"prefix":"10.3389","volume":"17","author":[{"given":"Omid","family":"Mirmosayyeb","sequence":"first","affiliation":[{"name":"Department of Neurological Sciences, University of Vermont","place":["Burlington, VT, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"664664","DOI":"10.3389\/fneur.2021.664664","article-title":"Autoimmune disorders of the nervous system: pathophysiology, clinical features, and therapy","volume":"12","author":"Bhagavati","year":"2021","journal-title":"Front Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"106456","DOI":"10.1016\/j.msard.2025.106456","article-title":"Brain health\u2013time matters: multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and related conditions","volume":"101","author":"Butzkueven","year":"2025","journal-title":"Mult Scler Relat Disord."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1007\/s00415-023-11685-3","article-title":"Autoimmune encephalitis: recent clinical and biological advances","volume":"270","author":"Varley","year":"2023","journal-title":"J Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-025-01133-3","article-title":"The changing landscape of primary autoimmune neuropathies","volume":"21","author":"Caballero-\u00c1vila","year":"2025","journal-title":"Nat Rev Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejpn.2017.11.010","article-title":"Principles and approaches to the treatment of immune-mediated movement disorders","volume":"22","author":"Mohammad","year":"2018","journal-title":"Eur J Paediatr Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.3390\/biomedicines11092489","article-title":"A comprehensive review on neuroimmunology: insights from multiple sclerosis to future therapeutic developments","volume":"11","author":"Eva","year":"2023","journal-title":"Biomedicines"},{"key":"B7","doi-asserted-by":"publisher","first-page":"110746","DOI":"10.1016\/j.clinbiochem.2024.110746","article-title":"Autoimmune central nervous system disorders: Antibody testing and its clinical utility","volume":"126","author":"Gilligan","year":"2024","journal-title":"Clin Biochem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41582-024-01014-1","article-title":"NMOSD and MOGAD: an evolving disease spectrum","volume":"20","author":"Uzawa","year":"2024","journal-title":"Nat Rev Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"105829","DOI":"10.1016\/j.msard.2024.105829","article-title":"Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan","volume":"90","author":"Niino","year":"2024","journal-title":"Mult Scler Relat Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1129906","DOI":"10.3389\/fimmu.2023.1129906","article-title":"B cell targeted therapies in inflammatory autoimmune disease of the central nervous system","volume":"14","author":"Furman","year":"2023","journal-title":"Front Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"106667","DOI":"10.1016\/j.msard.2025.106667","article-title":"Prediction of long-term outcome in Multiple Sclerosis: a systematic review","volume":"2025","author":"Mrabet","year":"2025","journal-title":"Mult Scler Relat Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"106075","DOI":"10.1016\/j.msard.2024.106075","article-title":"Prognosis predictors in neuromyelitis optica spectrum disorder: a tunisian cohort study","volume":"92","author":"Othman","year":"2024","journal-title":"Mult Scler Relat Disord."},{"key":"B13","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.neurol.2024.07.002","article-title":"The immunology underlying CNS autoantibody diseases","volume":"180","author":"Cleaver","year":"2024","journal-title":"Rev Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/s41423-023-01092-z","article-title":"Neuroimmunology: reviews and perspectives on recent advances","volume":"20","author":"Qi","year":"2023","journal-title":"Cell Mol Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neuron.2024.12.006","article-title":"Toward curing neurological autoimmune disorders: biomarkers, immunological mechanisms, and therapeutic targets","volume":"113","author":"Segal","year":"2025","journal-title":"Neuron"},{"key":"B16","doi-asserted-by":"publisher","first-page":"13614","DOI":"10.3390\/ijms252413614","article-title":"Revolutionizing neuroimmunology: unraveling immune dynamics and therapeutic innovations in CNS disorders","volume":"25","author":"Toader","year":"2024","journal-title":"Int J Mol Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"102180","DOI":"10.1016\/j.coi.2022.102180","article-title":"Single-cell multiomics in neuroinflammation","volume":"76","author":"Ingelfinger","year":"2022","journal-title":"Curr Opin Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"106812","DOI":"10.1016\/j.msard.2025.106812","article-title":"CAR T cells for multiple sclerosis: engineering T cells to disrupt chronic B cell\u2013driven neuroinflammation","volume":"2025","author":"Ortu\u00f1o-Sahag\u00fan","year":"2025","journal-title":"Mult Scler Relat Disord."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1635989","DOI":"10.3389\/fimmu.2025.1635989","article-title":"B cell depletion as a therapeutic strategy for neuromyelitis optica spectrum disorder: rationale, evidence, and challenges","volume":"16","author":"Ochi","year":"2025","journal-title":"Front Immunol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1746702\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:32:45Z","timestamp":1771392765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1746702\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":19,"alternative-id":["10.3389\/fneur.2026.1746702"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1746702","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"article-number":"1746702"}}